Cancer Research

Silence Therapeutics Announces Successful Opposition Of Glover Patent

LONDON, July 11 /PRNewswire/-- Silence Therapeutics plc (London AIM: SLN), a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent r ...

Article - Anna Ohlden - Jul 11 2008 - 10:33am

Proteins And The Chamber Of Doom

Indiana Jones isn't the only one who has great adventures, apparently proteins do also. Researchers have uncovered a a slippery tube that funnels proteins into a 'chamber of doom' where they are shredded and recycled into the building blocks ...

Article - News Staff - Jul 12 2008 - 11:36am

Myosin-I Molecular Motor Detects Minute Changes In Force

Researchers at the University of Pennsylvania School of Medicine discovered that the activity of a specific family of nanometer-sized molecular motors called myosin-I is regulated by force. The motor puts tension on cellular springs that allow vibrations t ...

Article - News Staff - Jul 13 2008 - 12:23am

Raptor Pharmaceuticals Expands Board Of Directors And Scientific Advisory Board

NOVATO, California, July 14 /PRNewswire/-- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of directors and Stephen C. Blacklow, M.D., Ph.D. to its s ...

Article - Anna Ohlden - Jul 14 2008 - 6:32am

Ulcer Bacterium Found In 700 Year-Old Mexican Mummy

Remnants of the bacterium that causes stomach ulcers, Helicobacter pylori, (H. pylori) have been discovered in gastric tissue from North American mummies. A study of human remains believed to predate Columbus' discovery of the New World has shown for ...

Article - News Staff - Jul 14 2008 - 11:26pm

AMT Starts Collaboration With St. Jude Children's Research Hospital On Gene Therapy For Hemophilia B. Company Accesses Exclusive

AMSTERDAM, The Netherlands, July 15 /PRNewswire/-- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with St. Jude Children's Research Hospital in Memphis, Tenn ...

Article - Anna Ohlden - Jul 15 2008 - 12:32am

BioWa And Medarex Announce License Of BioWa's COMPLEGENT(TM) Technology

PRINCETON, New Jersey, July 16 /PRNewswire/-- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they have entered into a license agreement which provides Medarex with the first ever access to BioWa's COMPLEGENT(TM) Technology for enha ...

Article - Anna Ohlden - Jul 16 2008 - 5:31am

Raptor Pharmaceuticals Enters Collaboration Agreement With UC San Diego In Liver Disease

NOVATO, California, July 16 /PRNewswire/--- Raptor to Support Phase 2a Clinical Trial at UCSD Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreeme ...

Article - Anna Ohlden - Jul 16 2008 - 6:32am

Galderma Announces Approval For Differin(R) Gel 0.1% In Japan

LAUSANNE, Switzerland, July 17 /PRNewswire/--- Based on the Largest Ever Clinical Program for Acne in Japan Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor ...

Article - Anna Ohlden - Jul 16 2008 - 7:31pm

Organizational Changes At Silence Therapeutics

LONDON, July 17 /PRNewswire/-- Silence Therapeutics plc (London AIM: SLN), a leading European RNAi focused biotechnology company, announces that for personal reasons, Jeffery Vick has resigned as Group CEO and left the Company. The Board of Directors has ...

Article - Anna Ohlden - Jul 17 2008 - 11:31am